1. Home
  2. KTTA vs WTO Comparison

KTTA vs WTO Comparison

Compare KTTA & WTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KTTA
  • WTO
  • Stock Information
  • Founded
  • KTTA 2020
  • WTO 2008
  • Country
  • KTTA United States
  • WTO China
  • Employees
  • KTTA N/A
  • WTO N/A
  • Industry
  • KTTA Biotechnology: Pharmaceutical Preparations
  • WTO Consumer Electronics/Appliances
  • Sector
  • KTTA Health Care
  • WTO Technology
  • Exchange
  • KTTA Nasdaq
  • WTO Nasdaq
  • Market Cap
  • KTTA 2.8M
  • WTO 3.3M
  • IPO Year
  • KTTA 2021
  • WTO 2021
  • Fundamental
  • Price
  • KTTA $0.73
  • WTO $0.92
  • Analyst Decision
  • KTTA
  • WTO
  • Analyst Count
  • KTTA 0
  • WTO 0
  • Target Price
  • KTTA N/A
  • WTO N/A
  • AVG Volume (30 Days)
  • KTTA 222.0K
  • WTO 66.5K
  • Earning Date
  • KTTA 08-12-2025
  • WTO 07-29-2025
  • Dividend Yield
  • KTTA N/A
  • WTO N/A
  • EPS Growth
  • KTTA N/A
  • WTO N/A
  • EPS
  • KTTA N/A
  • WTO N/A
  • Revenue
  • KTTA N/A
  • WTO $32,309,502.00
  • Revenue This Year
  • KTTA N/A
  • WTO N/A
  • Revenue Next Year
  • KTTA N/A
  • WTO N/A
  • P/E Ratio
  • KTTA N/A
  • WTO N/A
  • Revenue Growth
  • KTTA N/A
  • WTO 47.36
  • 52 Week Low
  • KTTA $0.71
  • WTO $0.75
  • 52 Week High
  • KTTA $7.50
  • WTO $622.50
  • Technical
  • Relative Strength Index (RSI)
  • KTTA 33.06
  • WTO 39.41
  • Support Level
  • KTTA $0.71
  • WTO $0.75
  • Resistance Level
  • KTTA $0.80
  • WTO $1.06
  • Average True Range (ATR)
  • KTTA 0.04
  • WTO 0.08
  • MACD
  • KTTA 0.00
  • WTO 0.03
  • Stochastic Oscillator
  • KTTA 12.14
  • WTO 51.61

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

About WTO UTime Limited

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; and Do, as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

Share on Social Networks: